UK’s NICE rejects Novartis asthma drug in change of tack – Reuters


Daily Mail

UK's NICE rejects Novartis asthma drug in change of tack
Reuters
Health ». LONDON | Thu Nov 8, 2012 7:06pm EST. LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE plans to recommend against the use of Novartis's severe asthma drug Xolair, or omalizumab, after earlier endorsing it for adults only.
Now English asthma patients are denied life-changing drug offered to ScotsDaily Mail
Asthma drug life changing: swimmerMSN News UK

all 16 news articles »

View full post on asthma – Google News